Source: BioPortfolio

Asterias: BioTime Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update

Completed Acquisition of Asterias Biotherapeutics Inc. Completed Distribution of AgeX Therapeutics Shares to BioTime Shareholders Entered Into Exclusive Collaboration with Orbit Biomedical Ltd. ...

Read full article »
Asterias's Competitors | Asterias's News | Asterias's Financials
Stay up-to-date with the latest news on Asterias Biotherapeutics, Inc.
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100

Read more
Stay up-to-date with the latest news on Asterias Biotherapeutics, Inc.